Search

Salt marshes are crucial eco-geomorphic features of tidal environments as they provide important ecological functions and deliver a wide range of ecosystem services. Being controlled by the interplay between hydrodynamics, geomorphology, and vegetation, the contribution of both organic matter (OM) and inorganic sediments drives salt marsh vertical accretion. This allows marshes to keep pace with relative sea level rise and likewise capture and store carbon, making them valuable allies in climate mitigation strategies. Thus, soil organic matter (SOM), i.e. the organic component of the soil, plays a key role within salt marsh environments, directly contributing to soil formation and supporting carbon storage. This study aims at inspecting spatial patterns of OM in surface salt marsh soils (top 20 cm), providing further insights into the physical and biological factors driving OM dynamics that affect salt marsh survival and carbon sink potential. Our results reveal two scales of variations in SOM content in marsh environments. At the marsh scale, OM variability is influenced by the interplay between surface elevation and changes in sediment supply linked with the distance from the marsh edge. At the system scale, OM content distribution is dominated by the gradient generated by marine and fluvial influence. The observed variations in SOM are explained by the combination of inorganic and organic input, preservation conditions, and sediment grain size. Our results highlight the importance of marshes as carbon sink environments, further emphasising that environmental conditions within a tidal system may generate strongly variable and site-specific carbon accumulation patterns, enhancing blue carbon assessment complexity. [ABSTRACT FROM AUTHOR]

Salt marshes are crucial eco-geomorphic features of tidal environments as they provide numerous important ecological functions and deliver a wide range of ecosystem services that contribute to human well-being. Being controlled by the interplay between hydrodynamics, geomorphology and vegetation, the deposition of both organic matter (OM) and inorganic sediments drives salt-marsh vertical accretion. This allows marshes to keep pace with relative sea-level rise, and likewise capture and store carbon, making them valuable allies in climate mitigation strategies. Thus, Soil Organic Matter (SOM), i.e. the organic component of the soil, plays a key role within salt-marsh environments, directly contributing to soil formation and supporting carbon storage. This study aims at inspecting spatial patterns of OM in surface salt-marsh soils, providing further insights into the physical and biological factors driving OM dynamics, affecting salt-marsh survival and carbon sink potential. Our results reveal two scales of variations in sedimentary OM content in salt-marsh soils. At the marsh scale OM variability is influenced by the interplay between surface elevation and changes in sediment supply linked with the distance from tidal channels. At the system scale, OM content distribution is dominated by the gradient generated by marine and fluvial influence. Variations in inorganic and organic inputs, both autochthonous and allochthonous, sediment grain size, and preservation conditions may explain the observed variations in SOM. Our results highlight marsh importance as carbon sink environments, furthermore emphasizing that environmental conditions within a tidal system may generate strongly variable and site-specific carbon accumulation patterns, enhancing blue carbon assessment complexity. [ABSTRACT FROM AUTHOR]

Recently, the atrial fibrillation treatment guidelines have been updated to now recommend Non-vitamin K antagonist oral anticoagulants (NOACs) as the preferred alternative to warfarin for systemic embolism and stroke prevention in patients with non-valvular atrial fibrillation. NOACs have major pharmacologic advantages over warfarin, although the most common complications are gastrointestinal bleeding and NOAC-induced nephropathy within 6 weeks after starting therapy, as several recent case-reports stated. We are reporting for the first time a chronic delayed adverse reaction (regularly reported to Authorities) observed in an 82-year-old woman 27 months after starting dabigatran (110 mg twice a day), characterized by concomitant gastrointestinal bleeding and nephropathy. Idarucizumab administration immediately improved both bleeding and renal parameters. Moreover, we are going to highlight the importance of the compliance, the adherence to the therapeutic plan and the supervision of the Hospital Pharmacy on drug prescriptions. In fact in our case, dabigatran was firstly prescribed by the neurologist and delivered by the hospital pharmacy, but the patient continued the treatment for 27 months, prescribed by general practitioner without any laboratory control. This lack of supervision certainly contributed to the onset of the adverse reaction reported. [ABSTRACT FROM AUTHOR]

At INFN-LNL (Istituto Nazionale di Fisica Nucleare- Laboratori Nazionali di Legnaro) SPES (Selective Production of Exotic Species), a new facility for the production of radioactive ion beams is being constructed at INFN-LNL (Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali di Legnaro). Radioactive ion beams of neutron-rich nuclei with high purity, in the range of mass between 80 and 160 amu, will be produced by nuclear reactions induced by 40 MeV protons from a cyclotron. The goal of the ISOLPHARM project is to provide a feasibility study for an innovative technology for the production of extremely very high specific activity beta emitting radionuclides as radiopharmaceutical precursors. The ISOL method, adopted in the ISOLPHARM project (a branch of the SPES project), gives the possibility of obtaining pure isobaric beams. In this way, no isotopic contaminations will be present in the beam and afterwards in a proper trapping substrate. The ground-breaking idea of the ISOLPHARM method was granted an International patent (INFN). [ABSTRACT FROM AUTHOR]

Objectives: The transplantation of human tissues is a greatly expanding field of medicine with unquestionable benefits that raise questions about safety, quality and ethics. Since 1 October 2019, the Fondazione Banca dei Tessuti del Veneto (FBTV) stopped sending thawed and ready to be transplanted cadaveric human tissues to hospitals. A retrospective analysis of the period 2016-2019 found a significant number of unused tissues. For this reason, the hospital pharmacy has developed a new centralised service characterised by thawing and washing human tissues for orthopaedic allografts. This study aims to analyse the hospital cost and benefit derived from this new service., Methods: Aggregate data relating to tissue flows were obtained retrospectively for the period 2016-2022 through the hospital data warehouse. All tissues arriving from FBTV for each year were analysed, dividing them according to the outcome (if used or wasted). The percentage of wasted tissues as well as the economic loss due to wasted allografts were analysed per year and trimester., Results: We identified 2484 allografts requested for the period 2016-2022. In the last 3 years of the analysis, characterised by the new tissue management of the pharmacy department, we found a statistically significant reduction in wasted tissues (p<0.0001) from 16.33% (216/1323) with a cost to the hospital of 176 866€ during the period 2016-2019 to 6.72% (78/1161) with a cost to the hospital of 79 423€ during the period 2020-2022., Conclusion: This study shows how the centralised processing of human tissues in the hospital pharmacy makes the procedure safer and more efficient, demonstrating how the synergy between different hospital departments, high professional skills and ethics can lead to a clinical advantage for patients and a better economic impact for the hospital., Competing Interests: Competing interests: None declared., (© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.)

Chronic gastro-duodenal reflux in the esophagus is a major risk for intestinal metaplasia and Barrett's adenocarcinoma. A role for chronic use of proton pump inhibitor (PPI) in the increased incidence of esophageal adenocarcinoma in Western countries has been previously suggested. The aim of this work was to study the effect of chronic administration of omeprazole (a proton pump inhibitor) per os in a model of reflux induced esophageal carcinogenesis. One week after esophago-gastro-jejunostomy, 115 Sprague-Dawley rats were randomized to receive 10 mg/Kg per day of omeprazole or placebo, 5 days per week. The esophago-gastric specimens were collected 28 ± 2 weeks after randomization and analyzed in a blinded fashion. Mortality and esophageal metaplasia rates did not differ between the two groups (p = 0.99 for mortality, p = 0.36 for intestinal metaplasia and p = 0.66 for multi-layered epithelium). Gastric pancreatic acinar cell metaplasia (PACM) was more frequently observed in PPI-treated rats (p = 0.003). Severe ulcer lesions significantly prevailed in the placebo group (p = 0.03). Locally invasive esophageal epithelial neoplasia were observed in 23/39 PPI-treated versus 14/42 placebo-animals (p = 0.03). In conclusion, chronic omeprazole treatment improved the healing of esophageal ulcerative lesions. Locally invasive neoplastic lesions and PACM prevailed among PPI-treated animals. However, neither an effect on the overall mortality nor on the incidence of pre-neoplastic lesions was observed in this work.